- Home
- NITO vs SONN Comparison
NITO vs SONN Comparison
Compare NITO & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NITO
- SONN
- Stock Information
- Founded
- NITO 2009
- SONN N/A
- Country
- NITO Israel
- SONN United States
- Employees
- NITO N/A
- SONN N/A
- Industry
- NITO
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- NITO
- SONN Health Care
- Exchange
- NITO NYSE
- SONN Nasdaq
- Market Cap
- NITO 2.2M
- SONN 2.5M
- IPO Year
- NITO N/A
- SONN N/A
- Fundamental
- Price
- NITO $1.37
- SONN $1.78
- Analyst Decision
- NITO
- SONN Strong Buy
- Analyst Count
- NITO 0
- SONN 2
- Target Price
- NITO N/A
- SONN $38.00
- AVG Volume (30 Days)
- NITO 50.6M
- SONN 2.8M
- Earning Date
- NITO 11-14-2024
- SONN 02-12-2025
- Dividend Yield
- NITO N/A
- SONN N/A
- EPS Growth
- NITO N/A
- SONN N/A
- EPS
- NITO N/A
- SONN N/A
- Revenue
- NITO $175,308.00
- SONN $18,626.00
- Revenue This Year
- NITO N/A
- SONN N/A
- Revenue Next Year
- NITO N/A
- SONN N/A
- P/E Ratio
- NITO N/A
- SONN N/A
- Revenue Growth
- NITO N/A
- SONN N/A
- 52 Week Low
- NITO $0.16
- SONN $1.41
- 52 Week High
- NITO $3.49
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- NITO 61.81
- SONN 46.72
- Support Level
- NITO $0.23
- SONN $1.41
- Resistance Level
- NITO $3.49
- SONN $2.52
- Average True Range (ATR)
- NITO 0.28
- SONN 0.20
- MACD
- NITO 0.18
- SONN 0.12
- Stochastic Oscillator
- NITO 36.32
- SONN 45.95
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.